Effective and acceptable treatment for depression.
作者信息
Madeley P, Wattis J P
出版信息
BMJ. 1993 Apr 24;306(6885):1126; author reply 1126-7. doi: 10.1136/bmj.306.6885.1126-a.
Abstract
摘要
相似文献
1
Effective and acceptable treatment for depression.针对抑郁症的有效且可接受的治疗方法。
BMJ. 1993 Apr 24;306(6885):1126; author reply 1126-7. doi: 10.1136/bmj.306.6885.1126-a.
2
Selective serotonin reuptake inhibitors for depression?用于治疗抑郁症的选择性5-羟色胺再摄取抑制剂？
Drug Ther Bull. 1993 Jul 19;31(15):57-8.
3
Selective serotonin reuptake inhibitors: adverse effects, toxicity and interactions.选择性5-羟色胺再摄取抑制剂：不良反应、毒性及相互作用。
Adverse Drug React Toxicol Rev. 1994 Autumn;13(3):121-44.
4
[Antidepressants in depression of the elderly].[老年抑郁症中的抗抑郁药]
Ugeskr Laeger. 2007 Aug 13;169(33):2625-7.
5
Mirtazapine as an alternative for selective-serotonin-reuptake-inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone.米氮平作为选择性5-羟色胺再摄取抑制剂所致抗利尿激素分泌不当综合征的一种替代药物。
Psychiatry Clin Neurosci. 2012 Feb;66(1):80. doi: 10.1111/j.1440-1819.2011.02297.x.
6
[Drug therapy for patients with depression].[抑郁症患者的药物治疗]
Seishin Shinkeigaku Zasshi. 2001;103(8):596-601.
7
Serotonin syndrome as a result of clomipramine monotherapy.
J Clin Psychopharmacol. 1999 Jun;19(3):285-7. doi: 10.1097/00004714-199906000-00021.
8
WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).撤回：选择性5-羟色胺再摄取抑制剂（SSRI）与三环类抗抑郁药（TCA）停药情况对比
Cochrane Database Syst Rev. 2007 Jul 18(3):CD002791. doi: 10.1002/14651858.CD002791.pub2.
9
Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.选择性5-羟色胺再摄取抑制剂与三环类及杂环类抗抑郁药：药物依从性比较
Cochrane Database Syst Rev. 2000(4):CD002791. doi: 10.1002/14651858.CD002791.
10
[Mirtazapine versus other antidepressive agents for depression].[米氮平与其他抗抑郁药治疗抑郁症的比较]
Ugeskr Laeger. 2012 Nov 12;174(46):2864-6.
引用本文的文献
1
Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analyses.抗抑郁药处方的限制及抗抑郁药成本效益使用原则。第2部分：成本效益分析。
Pharmacoeconomics. 1997 Jun;11(6):515-37. doi: 10.2165/00019053-199711060-00002.
本文引用的文献
1
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.选择性5-羟色胺再摄取抑制剂：疗效与可接受性的荟萃分析
BMJ. 1993 Mar 13;306(6879):683-7. doi: 10.1136/bmj.306.6879.683.
2
Fluoxetine versus trazodone in depressed geriatric patients.氟西汀与曲唑酮治疗老年抑郁症患者的比较。
J Geriatr Psychiatry Neurol. 1989 Oct-Dec;2(4):208-14. doi: 10.1177/089198878900200407.
3
A review of the psychomotor effects of paroxetine.帕罗西汀的精神运动效应综述。
Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:65-7. doi: 10.1097/00004850-199206004-00012.
Zotero 插件